237 related articles for article (PubMed ID: 24750743)
1. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.
Liu Y; Kong M; Feng C; Yang KK; Li Y; Su J; Cheng XJ; Park HJ; Chen XG
Colloids Surf B Biointerfaces; 2013 Mar; 103():345-53. PubMed ID: 23247264
[TBL] [Abstract][Full Text] [Related]
4. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
5. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
6. Nano-polyplex based on oleoyl-carboxymethy-chitosan (OCMCS) and hyaluronic acid for oral gene vaccine delivery.
Liu Y; Wang FQ; Shah Z; Cheng XJ; Kong M; Feng C; Chen XG
Colloids Surf B Biointerfaces; 2016 Sep; 145():492-501. PubMed ID: 27236511
[TBL] [Abstract][Full Text] [Related]
7. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
8. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers.
Liu Y; Cheng XJ; Dang QF; Ma FK; Chen XG; Park HJ; Kim BK
J Mater Sci Mater Med; 2012 Feb; 23(2):375-84. PubMed ID: 22139537
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles.
Moghaddam FA; Atyabi F; Dinarvand R
Nanomedicine; 2009 Jun; 5(2):208-15. PubMed ID: 19186220
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery.
Liu Y; Kong M; Cheng XJ; Wang QQ; Jiang LM; Chen XG
Carbohydr Polym; 2013 Apr; 94(1):309-16. PubMed ID: 23544543
[TBL] [Abstract][Full Text] [Related]
12. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
13. Hydrocaffeic acid-chitosan nanoparticles with enhanced stability, mucoadhesion and permeation properties.
Soliman GM; Zhang YL; Merle G; Cerruti M; Barralet J
Eur J Pharm Biopharm; 2014 Nov; 88(3):1026-37. PubMed ID: 25281213
[TBL] [Abstract][Full Text] [Related]
14. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
[TBL] [Abstract][Full Text] [Related]
15. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
16. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.
Sandri G; Poggi P; Bonferoni MC; Rossi S; Ferrari F; Caramella C
J Pharm Pharmacol; 2006 Oct; 58(10):1327-36. PubMed ID: 17034655
[TBL] [Abstract][Full Text] [Related]
17. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
18. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
20. Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Siew A; Le H; Thiovolet M; Gellert P; Schatzlein A; Uchegbu I
Mol Pharm; 2012 Jan; 9(1):14-28. PubMed ID: 22047066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
